Bristol HIV Price Cut Includes Pledge Not To Enforce Patent Rights In Africa

Bristol-Myers Squibb's HIV drug price cut for sub-Saharan African countries includes a pledge not to enforce patent rights for Videx (didanosine) and Zerit (stavudine).

More from Archive

More from Pink Sheet